Statistical Properties of the Design for Simultaneous Global Drug Development Program.

J Biopharm Stat

b Biostatistics, Johnson & Johnson , Raritan, New Jersey , USA.

Published: July 2016

Recently, a design was proposed for the Simultaneous Global Drug Development Program (SGDDP) to assess the impact of ethnic factors on the effect of a new treatment for a targeted ethnic (TE) population. It used weighted Z tests to combine the information collected from the TE and non-TE (NTE) subgroups in the SGDDP based on the fundamental assumption on their shared biological commonality. In this article, we mathematically formulated this assumption as the quantitative interaction between treatment effect and subgroup. We used it to more rigorously describe the hypotheses, and showed the unbiasedness of the weighted Z test. Moreover, to study the loss of efficiency from down weighting the NTE information in this SGDDP design, we compared the power of their test with that of the uniformly most powerful (UMP) test, which we showed was also a weighted Z test. We discussed that the choice of weight should balance the maximization of power when the assumption holds and the minimization of bias otherwise.

Download full-text PDF

Source
http://dx.doi.org/10.1080/10543406.2014.971166DOI Listing

Publication Analysis

Top Keywords

simultaneous global
8
global drug
8
drug development
8
development program
8
weighted test
8
statistical properties
4
properties design
4
design simultaneous
4
program design
4
design proposed
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!